Black elderberry extract attenuates inflammation and metabolic dysfunction in diet-induced obese mice. 2015

Nicholas J Farrell, and Gregory H Norris, and Julia Ryan, and Caitlin M Porter, and Christina Jiang, and Christopher N Blesso
Department of Nutritional Sciences,University of Connecticut,Storrs,CT 06269,USA.

Dietary anthocyanins have been shown to reduce inflammation in animal models and may ameliorate obesity-related complications. Black elderberry is one of the richest sources of anthocyanins. We investigated the metabolic effects of anthocyanin-rich black elderberry extract (BEE) in a diet-induced obese C57BL/6J mouse model. Mice were fed either a low-fat diet (n 8), high-fat lard-based diet (HFD; n 16), HFD+0·25 % (w/w) BEE (0·25 %-BEE; n 16) or HFD+1·25 % BEE (1·25 %-BEE; n 16) for 16 weeks. The 0·25 % BEE (0·034 % anthocyanin, w/w) and 1·25 % BEE (0·17 % anthocyanin, w/w) diets corresponded to estimated anthocyanin doses of 20-40 mg and 100-200 mg per kg of body weight, respectively. After 16 weeks, both BEE groups had significantly lower liver weights, serum TAG, homoeostasis model assessment and serum monocyte chemoattractant protein-1 compared with HFD. The 0·25 %-BEE also had lower serum insulin and TNFα compared with HFD. Hepatic fatty acid synthase mRNA was lower in both BEE groups, whereas PPARγ2 mRNA and liver cholesterol were lower in 1·25 %-BEE, suggesting decreased hepatic lipid synthesis. Higher adipose PPARγ mRNA, transforming growth factor β mRNA and adipose tissue histology suggested a pro-fibrogenic phenotype that was less inflammatory in 1·25 %-BEE. Skeletal muscle mRNA expression of the myokine IL-6 was higher in 0·25 %-BEE relative to HFD. These results suggest that BEE may have improved some metabolic disturbances present in this mouse model of obesity by lowering serum TAG, inflammatory markers and insulin resistance.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008820 Mice, Obese Mutant mice exhibiting a marked obesity coupled with overeating, hyperglycemia, hyperinsulinemia, marked insulin resistance, and infertility when in a homozygous state. They may be inbred or hybrid. Hyperglycemic Mice,Obese Mice,Mouse, Hyperglycemic,Mouse, Obese,Hyperglycemic Mouse,Mice, Hyperglycemic,Obese Mouse
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body

Related Publications

Nicholas J Farrell, and Gregory H Norris, and Julia Ryan, and Caitlin M Porter, and Christina Jiang, and Christopher N Blesso
October 2014, The Journal of nutritional biochemistry,
Nicholas J Farrell, and Gregory H Norris, and Julia Ryan, and Caitlin M Porter, and Christina Jiang, and Christopher N Blesso
June 2018, Molecular neurobiology,
Nicholas J Farrell, and Gregory H Norris, and Julia Ryan, and Caitlin M Porter, and Christina Jiang, and Christopher N Blesso
October 2017, Scientific reports,
Nicholas J Farrell, and Gregory H Norris, and Julia Ryan, and Caitlin M Porter, and Christina Jiang, and Christopher N Blesso
June 2022, Foods (Basel, Switzerland),
Nicholas J Farrell, and Gregory H Norris, and Julia Ryan, and Caitlin M Porter, and Christina Jiang, and Christopher N Blesso
February 2014, Free radical biology & medicine,
Nicholas J Farrell, and Gregory H Norris, and Julia Ryan, and Caitlin M Porter, and Christina Jiang, and Christopher N Blesso
July 2018, Journal of ginseng research,
Nicholas J Farrell, and Gregory H Norris, and Julia Ryan, and Caitlin M Porter, and Christina Jiang, and Christopher N Blesso
August 2022, Pharmaceutics,
Nicholas J Farrell, and Gregory H Norris, and Julia Ryan, and Caitlin M Porter, and Christina Jiang, and Christopher N Blesso
May 2019, Journal of ethnopharmacology,
Nicholas J Farrell, and Gregory H Norris, and Julia Ryan, and Caitlin M Porter, and Christina Jiang, and Christopher N Blesso
October 2012, Nutrition (Burbank, Los Angeles County, Calif.),
Nicholas J Farrell, and Gregory H Norris, and Julia Ryan, and Caitlin M Porter, and Christina Jiang, and Christopher N Blesso
January 2012, PloS one,
Copied contents to your clipboard!